Sep 2, 2025 07:47AM
Nov 2, 2023 06:31AM
Nov 2, 2023 06:30AM
Sep 1, 2021 01:44PM
Aug 6, 2021 06:30AM
Jul 1, 2021 06:31AM
Jul 1, 2021 06:30AM Immunic, Inc. Announces FDA Clearance to Begin IMU-838 Phase 3 ENSURE Studies in Relapsing-Remitting Multiple Sclerosis and Phase 2 CALLIPER Study in Progressive Multiple Sclerosis
May 6, 2021 06:30AM
Apr 15, 2021 06:31AM
Apr 15, 2021 06:30AM
Feb 18, 2021 06:45AM
Feb 18, 2021 06:30AM
Nov 17, 2020 06:30AM
Nov 2, 2020 06:38AM Immunic Inc. (IMUX) Reports 200 Patients Enrolled in Phase 2 CALVID-1 Trial of IMU-838 for Treatment of Moderate COVID-1
Nov 2, 2020 06:30AM
Sep 4, 2020 12:00AM
Aug 26, 2020 09:23AM
Aug 3, 2020 09:31AM
Jul 20, 2020 09:33AM
Jun 15, 2020 06:30AM
Jun 15, 2020 06:30AM Immunic, Inc. Announces First Patients Dosed in its Phase 2, CALVID-1 Clinical Trial of IMU-838 in COVID-19
Jun 9, 2020 07:04AM
Jun 9, 2020 07:00AM
May 11, 2020 09:28AM
Sep 5, 2019 04:01PM
Sep 5, 2019 04:00PM
Aug 12, 2019 06:30AM
Jul 11, 2019 08:55AM Pre-Open Movers 07/11: (IMUX) (OMER) (DVAX) (CI) (CVS) (WW) (SNSS) (BBBY) (FAST) (more...)
Apr 23, 2019 06:59AM

322,098 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All